177 related articles for article (PubMed ID: 30714958)
1. Alzheimer's Disease Markers in Aged ApoE-PON1 Deficient Mice.
Aluganti Narasimhulu C; Mitra C; Bhardwaj D; Burge KY; Parthasarathy S
J Alzheimers Dis; 2019; 67(4):1353-1365. PubMed ID: 30714958
[TBL] [Abstract][Full Text] [Related]
2. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
3. Fragmentation of brain apolipoprotein E (ApoE) and its relevance in Alzheimer's disease.
Amponsah AE; Feng B; Guo R; Zhang W; He J; Kong D; Dong T; Ma J; Cui H
Rev Neurosci; 2020 Aug; 31(6):589-603. PubMed ID: 32364519
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
5. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
6. Elderly apolipoprotein E‑/‑ mice with advanced atherosclerotic lesions in the aorta do not develop Alzheimer's disease-like pathologies.
Shnerb Ganor R; Harats D; Schiby G; Rosenblatt K; Lubitz I; Shaish A; Salomon O
Mol Med Rep; 2018 Feb; 17(2):2488-2492. PubMed ID: 29207114
[TBL] [Abstract][Full Text] [Related]
7. Correlation analysis of capillary APOE, VEGF and eNOS expression in Alzheimer brains.
Provias J; Jeynes B
Curr Alzheimer Res; 2011 Mar; 8(2):197-202. PubMed ID: 21143177
[TBL] [Abstract][Full Text] [Related]
8. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.
Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T
Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417
[TBL] [Abstract][Full Text] [Related]
9. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
10. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD
Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.
Lippa CF; Smith TW; Saunders AM; Hulette C; Pulaski-Salo D; Roses AD
Neurology; 1997 Feb; 48(2):515-9. PubMed ID: 9040748
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
Schwab C; Hosokawa M; McGeer PL
Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802
[TBL] [Abstract][Full Text] [Related]
13. A quantitative and immunohistochemical study on apolipoprotein E in brain tissue in Alzheimer's disease.
Hesse C; Bogdanovic N; Davidsson P; Blennow K
Dement Geriatr Cogn Disord; 1999; 10(6):452-9. PubMed ID: 10559559
[TBL] [Abstract][Full Text] [Related]
14. Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques.
Abner EL; Neltner JH; Jicha GA; Patel E; Anderson SL; Wilcock DM; Van Eldik LJ; Nelson PT
J Alzheimers Dis; 2018; 64(4):1307-1324. PubMed ID: 30040735
[TBL] [Abstract][Full Text] [Related]
15. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
[TBL] [Abstract][Full Text] [Related]
16. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.
Olichney JM; Hansen LA; Hofstetter CR; Lee JH; Katzman R; Thal LJ
Arch Neurol; 2000 Jun; 57(6):869-74. PubMed ID: 10867785
[TBL] [Abstract][Full Text] [Related]
17. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
[TBL] [Abstract][Full Text] [Related]
18. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
[TBL] [Abstract][Full Text] [Related]
19. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease.
Glöckner F; Meske V; Ohm TG
Neuroscience; 2002; 114(4):1103-14. PubMed ID: 12379263
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
